Japanese Pegylated Interferon (PegIFN) Alfa-2b/Ribavirin (RBV) Combination Trial
Clinical trial NCT01579474 · COMPLETED
Trial details
- NCT number
- NCT01579474
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-04-01
- Primary completion
- 2013-12-01
- Enrollment
- 131
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.